about
The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiationskNAC depletion stimulates myoblast migration and perturbs sarcomerogenesis by enhancing calpain 1 and 3 activityIKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesisp204 protein overcomes the inhibition of core binding factor alpha-1-mediated osteogenic differentiation by Id helix-loop-helix proteins.NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseasesThe retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the Cbfa1 transcription factor thereby increasing its activity.Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.Beta-catenin interacts with MyoD and regulates its transcription activity.NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.Nerve growth factor induces cell cycle arrest of astrocytes.The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors.Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.
P2860
Q28506894-4733B449-1BF2-43C3-8813-9697292E5A7AQ28513717-7DEFF77B-DA00-4141-A0E9-9C701092D2C6Q36492044-424287B6-0AF2-46C9-A971-287605285A89Q36625842-3CD5E875-7ED7-4A5B-A9C0-BC22D8B783B4Q36631181-FD66FA5C-9806-4DB0-8BA4-2154AA0A4C2FQ37075935-1B9962AA-9329-4D23-AE0C-A8AAB43176FAQ38302662-7CD883A3-8441-4CE7-B45D-EE610ECE7092Q39615856-BEF059D5-998F-4A3A-8C37-E500F75FC364Q40006362-DE311566-FD42-4D59-AA64-FCF07495DFC1Q40145024-E32433FB-D6D1-4C6D-A9A8-BCB51707F9ABQ40435871-75828E4A-FBEC-4C3D-B6E2-C1FDE6B74DE5Q42260357-638EFB02-2DFF-457F-B035-66A70A2AC378Q42413112-7BCDA39D-3B79-4179-B997-3C8BDE038084Q48026564-455E0B8D-8B49-49A3-B1D7-75292F76D33DQ52873956-63A79745-25CD-4797-BD07-4AA85C848D6BQ54979148-C9BB5A84-4E85-46A7-B528-09A46476CED2
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
RIP2, a checkpoint in myogenic differentiation
@nl
RIP2, a checkpoint in myogenic differentiation.
@ast
RIP2, a checkpoint in myogenic differentiation.
@en
type
label
RIP2, a checkpoint in myogenic differentiation
@nl
RIP2, a checkpoint in myogenic differentiation.
@ast
RIP2, a checkpoint in myogenic differentiation.
@en
prefLabel
RIP2, a checkpoint in myogenic differentiation
@nl
RIP2, a checkpoint in myogenic differentiation.
@ast
RIP2, a checkpoint in myogenic differentiation.
@en
P2093
P2860
P1476
RIP2, a checkpoint in myogenic differentiation.
@en
P2093
Barbara Munz
Eberhard Hildt
Helen M Blau
Matthew L Springer
P2860
P304
P356
10.1128/MCB.22.16.5879-5886.2002
P407
P577
2002-08-01T00:00:00Z